Serotonergic Neurotoxicity of 3,4-(±)-Methylenedioxyamphetamine and 3,4-(±)-Methylendioxymethamphetamine (Ecstasy) Is Potentiated by Inhibition of γ-Glutamyl Transpeptidase
- 31 May 2001
- journal article
- Published by American Chemical Society (ACS) in Chemical Research in Toxicology
- Vol. 14 (7) , 863-870
- https://doi.org/10.1021/tx010011l
Abstract
Reactive metabolites play an important role in 3,4-(±)-methylenedioxyamphetamine (MDA) and 3,4-(±)-methylenedioxymethamphetamine (MDMA; ecstasy)-mediated serotonergic neurotoxicity, although the specific identity of such metabolites remains unclear. 5-(Glutathion-S-yl)-α-methyldopamine (5-GSyl-α-MeDA) is a serotonergic neurotoxicant found in the bile of MDA-treated rats. The brain uptake of 5-GSyl-α-MeDA is decreased by glutathione (GSH), but sharply increases in animals pretreated with acivicin, an inhibitor of γ-glutamyl transpeptidase (γ-GT) suggesting competition between intact 5-GSyl-α-MeDA and GSH for the putative GSH transporter. γ-GT is enriched in blood−brain barrier endothelial cells and is the only enzyme known to cleave the γ-glutamyl bond of GSH. We now show that pretreatment of rats with acivicin (18 mg/kg, ip) inhibits brain microvessel endothelial γ-GT activity by 60%, and potentiates MDA- and MDMA-mediated depletions in serotonin (5-HT) and 5-hydroxylindole acidic acid (5-HIAA) concentrations in brain regions enriched in 5-HT nerve terminal axons (striatum, cortex, hippocampus, and hypothalamus). In addition, glial fibrillary acidic protein (GFAP) expression increases in the striatum of acivicin and MDA (10 mg/kg) treated rats, but remains unchanged in animals treated with just MDA (10 mg/kg). Inhibition of endothelial cell γ-GT at the blood−brain barrier likely enhances the uptake into brain of thioether metabolites of MDA and MDMA, such as 5-(glutathion-S-yl)-α-MeDA and 2,5-bis-(glutathion-S-yl)-α-MeDA, by increasing the pool of thioether conjugates available for uptake via the intact GSH transporter. The data indicate that thioether metabolites of MDA and MDMA contribute to the serotonergic neurotoxicity observed following peripheral administration of these drugs.Keywords
This publication has 16 references indexed in Scilit:
- Oxidative Metabolites of 5-S-Cysteinylnorepinephrine Are Irreversible Inhibitors of Mitochondrial Complex I and the α-Ketoglutarate Dehydrogenase and Pyruvate Dehydrogenase Complexes: Possible Implications for Neurodegenerative Brain DisordersChemical Research in Toxicology, 2000
- Microglial Response to Brain Injury: A Brief SynopsisToxicologic Pathology, 2000
- Glutathione and N-Acetylcysteine Conjugates of α-Methyldopamine Produce Serotonergic Neurotoxicity: Possible Role in Methylenedioxyamphetamine-Mediated NeurotoxicityChemical Research in Toxicology, 1999
- GSH Transport in Immortalized Mouse Brain Endothelial CellsJournal of Neurochemistry, 1999
- THE PHARMACOLOGY AND TOXICOLOGY OF POLYPHENOLIC-GLUTATHIONE CONJUGATESAnnual Review of Pharmacology and Toxicology, 1998
- 2,5-bis-(Glutathion-S-yl)-α-methyldopamine, a putative metabolite of (±)-3,4-methylenedioxyamphetamine, decreases brain serotonin concentrationsEuropean Journal of Pharmacology, 1997
- Effects of Intracerebroventricular Administration of 5-(Glutathion-S-yl)-α-methyldopamine on Brain Dopamine, Serotonin, and Norepinephrine Concentrations in Male Sprague-Dawley RatsChemical Research in Toxicology, 1996
- Synthesis and neurotoxicological evaluation of putative metabolites of the serotonergic neurotoxin 2-(methylamino)-1-[3,4-(methylenedioxy)phenyl]propane [(methylenedioxy)methamphetamine]Chemical Research in Toxicology, 1992
- Evidence for carrier-mediated transport of glutathione across the blood-brain barrier in the rat.Journal of Clinical Investigation, 1990
- Glutathione and Related γ-Glutamyl Compounds: Biosynthesis and UtilizationAnnual Review of Biochemistry, 1976